QuidelOrtho is dedicated to enhancing health outcomes through innovative diagnostic technologies that provide real-time, actionable intelligence across various healthcare settings. Their product offerings include advanced platforms such as the Solana® Molecular Testing Platform, Sofia® Platform, and the Ortho® Workstation Immunohematology Analyzer, which are designed to deliver precise and reliable results. The Vitros® Systems, known for their high-quality assays, utilize intelligent technologies to ensure accuracy and efficiency in laboratory testing. These systems are particularly noted for their ability to produce results with minimal sample sizes, catering to vulnerable patient populations while maintaining high standards of quality control.

In addition to their laboratory solutions, QuidelOrtho emphasizes the importance of research and development in advancing healthcare diagnostics. Their commitment to scientific exploration is evident in their extensive range of assays for various health conditions, including diabetes, infectious diseases, and autoimmune disorders. The company supports researchers with reliable diagnostic tools and reagents, contributing to over 1,000 published studies. By integrating cutting-edge technologies and a patient-focused design, QuidelOrtho aims to transform diagnostic data into meaningful health insights, ultimately driving better patient care and outcomes.

United States

QuidelOrtho develops and manufactures intelligent solutions that are transforming data into understanding and action for more people in more places every day, helping spot trends sooner, respond quicker and chart the course ahead with accuracy and confidence. Together, we are advancing diagnostics to power a healthier future.

QuidelOrtho

Company Details